Almirall S.A

Research Almirall S.A (E2Z) on Bullrun: market cap EUR 2.25B, P/E 37.0, dividend yield 1.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerE2Z
ExchangeF
CountrySpain
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencyEUR
Market capEUR 2.25B
P/E37.0
Dividend yield1.8%
Financial periodQ2 2026
RevenueEUR 310.32M
Net incomeEUR 24.25M
Free cash flowEUR 5.04M
Gross margin185.1%

Valuation Snapshot

latest market cap is EUR 2.25B; P/E is 37.0; dividend yield is 1.8%.

Peer valuation comparison

Latest P/E is 37x versus a Healthcare sector median of 24.46x (51.3% above).

Latest dividend yield is 1.8% versus a Healthcare sector median of 2.11% (14.7% below).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	EUR 1.37B	EUR 58.68M	EUR 37.15M	70.4%	n/a	EUR 337.77M	EUR 342.86M	EUR 1.49B
FY2024	EUR 985.72M	EUR 10.15M	EUR 130.93M	n/a	0.05	EUR 377.10M	EUR 408.81M	EUR 1.49B
FY2023	EUR 894.52M	EUR 38.47M	EUR 59.99M	n/a	-0.18	EUR 387.95M	n/a	EUR 1.46B
FY2022	EUR 863.25M	EUR 4.28M	EUR 132.10M	n/a	0.02	EUR 248.82M	n/a	EUR 1.32B

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-23	EUR 2.25B	37.0	1.8%	0.19

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.19 EUR, yield 1.8%.

Year	Dividends/share
FY2024	0.18 EUR
FY2023	0.18 EUR
FY2022	0.19 EUR

About Almirall S.A

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Related stock research

Spain stocks Spain Healthcare stocks A-Z stock index

Other Healthcare stocks

LABIANA HEALTH S.A.EO-10 (8RK) Faes Farma SA (FAE) Laboratorios Farmaceuticos ROVI (ROVI) Tubacex (0KD1) Prim S.A (5P1) Atrys Health SL (ATRY) Clinica Baviera (CBAV) Grifols SA (GRF-P) Grifols SA (GRFS) Oryzon Genomics SA (ORY) Grifols S.A (OZTA) Pharma Mar SAU (PMRA)

Frequently asked questions

What is Almirall S.A's market cap?

Almirall S.A's market capitalization is EUR 2.25B.

What is Almirall S.A's P/E ratio?

Almirall S.A's price-to-earnings (P/E) ratio is 37.0.

Does Almirall S.A pay a dividend?

Almirall S.A has a dividend yield of 1.8%.

What does Almirall S.A do?

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.